19-51338145-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001163922.3(VSIG10L):āc.1793T>Cā(p.Val598Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000178 in 1,535,364 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001163922.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSIG10L | NM_001163922.3 | c.1793T>C | p.Val598Ala | missense_variant | 6/10 | ENST00000335624.5 | NP_001157394.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSIG10L | ENST00000335624.5 | c.1793T>C | p.Val598Ala | missense_variant | 6/10 | 5 | NM_001163922.3 | ENSP00000335623 | P1 | |
VSIG10L | ENST00000600663.1 | n.411T>C | non_coding_transcript_exon_variant | 3/7 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000795 AC: 12AN: 150900Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000170 AC: 24AN: 141446Hom.: 1 AF XY: 0.000173 AC XY: 13AN XY: 75162
GnomAD4 exome AF: 0.000189 AC: 261AN: 1384346Hom.: 3 Cov.: 30 AF XY: 0.000214 AC XY: 146AN XY: 681636
GnomAD4 genome AF: 0.0000795 AC: 12AN: 151018Hom.: 0 Cov.: 31 AF XY: 0.000122 AC XY: 9AN XY: 73694
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2021 | The c.1793T>C (p.V598A) alteration is located in exon 6 (coding exon 6) of the VSIG10L gene. This alteration results from a T to C substitution at nucleotide position 1793, causing the valine (V) at amino acid position 598 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at